Financials
- Market Capitalization 635.36 M
- Employee 371
- Founded 2008
- CEO N/A
- Website www.regenxbio.com
- Headquarter Maryland, United States
- FIGI BBG007Z9V591
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.83
Rapporto prezzo/fatturato
4.36
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2746 | PTCT PTC Therapeutics, Inc. - Common Stock | 78.06 USD | -4.02% | -11.25% | +3.53% | +63.20% | 647.50 M USD | ||
| 2754 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.85 USD | -4.15% | -12.32% | -5.13% | +49.19% | 638.54 M USD | ||
| 2769 | PRME Prime Medicine, Inc. - Common Stock | 3.47 USD | -1.42% | -19.30% | +19.66% | -18.74% | 626.74 M USD | ||
| 2771 | MDXG MiMedx Group, Inc - Common Stock | 4.20 USD | +2.94% | +1.20% | +14.13% | -33.65% | 625.57 M USD |